| Bioactivity | Val-Cit-amide-Cbz-N(Me)-Maytansine is an antibody and bispecific antigen-binding mol. that bind hepatocyte growth factor receptor c-Met (MET) or antibody-drug conjugates (ADCs)[1]. |
| Name | Val-Cit-amide-Cbz-N(Me)-Maytansine |
| CAS | 1628543-59-8 |
| Formula | C55H78ClN9O15 |
| Molar Mass | 1140.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Schwartz, Gary;, et al. Methods of treating ocular cancer using anti-met antibodies and bispecific antigen binding molecules that bind Met. World Intellectual Property Organization, WO2020172475 A1 2020-08-27 |
Val-Cit-amide-Cbz-N(Me)-Maytansine
CAS: 1628543-59-8 F: C55H78ClN9O15 W: 1140.71
Val-Cit-amide-Cbz-N(Me)-Maytansine is an antibody and bispecific antigen-binding mol. that bind hepatocyte growth factor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.